Zhi Na, Mo Qian, Yang Shuo, Qin Yuan-Xing, Chen Hao, Wu Zeng-Guang, Lan Cai-Hong, Zhang Jun, Li Yin-Long
Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China.
Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China.
J Integr Med. 2021 Mar;19(2):185-190. doi: 10.1016/j.joim.2020.11.005. Epub 2020 Dec 5.
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.
一名61岁的新型冠状病毒肺炎(COVID-19)女性患者在口服中药汤剂治疗一个月后,未使用其他药物,其肺部炎症渗出、肺纤维化及生活质量均有显著改善。在治疗及随访的七周内未发现患者病情复发或恶化,也未发生不良事件,这表明口服中药汤剂能够改善COVID-19康复期患者的肺部炎症和纤维化,但仍需进一步研究。